-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Chembio Diagnostics, Inc. annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from 2010 to 2022.
- Chembio Diagnostics, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2022 was $0.000.
- Chembio Diagnostics, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was $0.000.
- Chembio Diagnostics, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was -$69.9K, a 82.4% increase from 2020.
- Chembio Diagnostics, Inc. annual Deferred Income Tax Expense (Benefit) for 2020 was -$396K, a 22.8% increase from 2019.
Deferred Income Tax Expense (Benefit), Trailing 12 Months (USD)
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)